---
title: "Lorundrostat (MLS-101) in Hypertension, in combination with other antihypertensive drugs: Effect on quality measures"
description: "Formulary evidence on Lorundrostat (MLS-101, MT-4129) in Hypertension, in combination with other antihypertensive drugs: Effect on quality measures. Topics: HEDIS Controlling High Blood Pressure (CBP), HEDIS Blood Pressure Control for Patients With Hypertension (BPC-E), Medicare Part C Star Ratings: Controlling Blood Pressure (C14), Medicare Part D Star Ratings: Medication Adherence for Hypertension (RAS antagonists) (D09), and 1 further topic. 5 evidence topics quoted from 4 sources."
canonical: "https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/product-information-and-disease-description/effect-on-quality-measures"
published: "2026-11-18T10:43:00-05:00"
modified: "2026-11-18T10:43:00-05:00"
---

# Lorundrostat (MLS-101) in Hypertension, in combination with other antihypertensive drugs: Effect on quality measures

<a id="heading-2.1.2.13"></a>

## 2.1.2.13 Effect of Lorundrostat on Quality Measures

<a id="topic-2.1.2.13-1"></a>

### HEDIS Controlling High Blood Pressure (CBP)

> “The percentage of persons 18–85 years of age who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately controlled (<140/90 mm Hg) during the measurement period.”

Source: [NCQA Controlling High Blood Pressure measure](https://www.ncqa.org/report-cards/health-plans/state-of-health-care-quality-report/controlling-high-blood-pressure-cbp/)

<a id="topic-2.1.2.13-2"></a>

### HEDIS Blood Pressure Control for Patients With Hypertension (BPC-E)

> “The percentage of persons 18–85 years of age who had a diagnosis of hypertension (HTN) and whose most recent blood pressure (BP) was <140/90 mm Hg during the measurement period.”

Source: [NCQA Blood Pressure Control for Patients With Hypertension measure](https://www.ncqa.org/report-cards/health-plans/state-of-health-care-quality-report/measures-list/blood-pressure-control-for-patients-with-hypertension-bpc-e/)

<a id="topic-2.1.2.13-3"></a>

### Medicare Part C Star Ratings: Controlling Blood Pressure (C14)

> “Percent of plan members with high blood pressure who got treatment and were able to maintain a healthy pressure.”
> “The percentage of MA members 18–85 years of age who had a diagnosis of hypertension (HTN) (denominator) and whose blood pressure (BP) was adequately controlled (less than 140/90 mm Hg) (numerator).”

Source: [CMS 2027 Part C and D Star Ratings Technical Notes (2026)](https://www.cms.gov/files/document/2027-tech-notes-2026-09-30.pdf)

<a id="topic-2.1.2.13-4"></a>

### Medicare Part D Star Ratings: Medication Adherence for Hypertension (RAS antagonists) (D09)

> “The percentage of plan members with a prescription for a blood pressure medication who fill their prescription often enough to cover 80% or more of the time they are taking the medication.”
> “This measure is defined as the percentage of Medicare Part D beneficiaries, 18 years and older, who adhere to their prescribed drug therapy for renin angiotensin system (RAS) antagonists: ACE inhibitor, ARB, or direct renin inhibitor medications.”

Source: [CMS 2027 Part C and D Star Ratings Technical Notes (2026)](https://www.cms.gov/files/document/2027-tech-notes-2026-09-30.pdf)

<a id="topic-2.1.2.13-5"></a>

### Medicare Star Ratings weights of the blood pressure measures, 2027

| Measure | Weighting category | Weight |
| --- | --- | --- |
| “Controlling Blood Pressure” | “Intermediate Outcome Measure” | “3” |
| “Medication Adherence for Hypertension (RAS antagonists)” | “Intermediate Outcome Measure” | “3” |

Source: [CMS 2027 Star Ratings Measures and Weights (2026)](https://www.cms.gov/files/document/2027-star-ratings-measures.pdf)

<a id="topic-2.1.2.13-6"></a>

### Product-specific effect on quality measures

No evidence found.

## Related pages
- [Lorundrostat (MLS-101): Hypertension, in combination with other antihypertensive drugs](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs) · [Markdown](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs.md)
- [Lorundrostat (MLS-101) in Hypertension, in combination with other antihypertensive drugs: Terms and abbreviations](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/terms-and-abbreviations.md)
- [Lorundrostat (MLS-101): Hypertension, in combination with other antihypertensive drugs](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/executive-summary) · [Markdown](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/executive-summary.md)
- [Lorundrostat (MLS-101) in Hypertension, in combination with other antihypertensive drugs: Product information and disease description](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/product-information-and-disease-description.md)
- [Lorundrostat (MLS-101) in Hypertension, in combination with other antihypertensive drugs: Clinical evidence](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/clinical-evidence.md)
- [Lorundrostat (MLS-101) in Hypertension, in combination with other antihypertensive drugs: Economic information and modeling report](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/economics) · [Markdown](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/economics.md)
- [Lorundrostat (MLS-101) in Hypertension, in combination with other antihypertensive drugs: References](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/references) · [Markdown](https://www.evicenter.com/drugs/lorundrostat--hypertension-in-combination-with-other-antihypertensive-drugs/references.md)
